The Evolving Landscape of HIV Prevention and Diagnosis

Similar documents
HIV Test Technologies, Best Practices, and New Algorithm. Jenny R. McFarlane DSHS HIV Prevention and Care Branch

New Generation of Nucleic Acid Testing. Michele Owen, Ph.D Division of HIV/AIDS Prevention Centers for Disease Control & Prevention

The Latest in HIV Tests: What Do the Results Mean?

HIV Testing Technology and the Latest Algorithm

1 st and 2 nd Generation EIA

Routine HIV Testing Community of Practice Session #2

Point-of-care HIV testing

Advantages and disadvantages of different types of FDA-approved HIV immunoassays used for screening by generation and platform*

New HIV Tests and Algorithm: A change we can believe in

Overview of HIV Testing Practices and Technology

ARCHITECT HIV Ag/Ab Combo: Moving HIV Diagnostics Forward in the U.S.

Learning Objectives. New HIV Testing Algorithm from CDC. Overview of HIV infection and disease 3/15/2016

Evolution of HIV Diagnostics. Goals for the 2010 Conference. Bernard M. Branson, M.D. CDC Division of HIV/AIDS Prevention

2018 HIV and HCV Diagnostic Testing Survey

A Summary of Clinical Evidence

Joanne Stekler, MD, MPH Assistant Professor of Medicine Deputy Director, Public Health Seattle & King County HIV/STD Program

List the steps in the fourth generation HIV screening algorithm Describe the relationship between rapid HIV antibody tests and the fourth generation

High Sensitivity HIV Testing and Translational Science around PrEP

Diagnostic Tests for HIV

HIV Update in Laboratory Testing. Patricia Slev, PhD, D(ABCC)

HIV: 2009 DIAGNOSTIC SURVEY FACING NEW CHALLENGES

INTEGRATING HIV AND HCV TESTING

Failure of the Alere Determine 4th Generation HIV POC test to Detect an Acute Case of HIV-1 Infection

Adventures in Discordance- HIV Testing

HIV/HCV Screening in 2015: Where Are We Now? Bernard M. Branson, M.D.

Diagnosis and Management of Acute HIV

Guidelines for Implementing Pre-Exposure Prophylaxis For The Prevention of HIV in Youth Peter Havens, MD MS Draft:

Arizona State Office of Rural Health Webinar Series

NEW CHALLENGES FOR ACCURATE HIV-1 DIAGNOSIS ALL BELGIAN AIDS REFERENCE LABORATORIES KAROLIEN STOFFELS (ARL VUB STP) & FIEN VANROYE (ARL ITM)

APHL/CDC HIV Demonstration Project Demonstration Project for HIV Nucleic Acid Testing (NAT) Referral Updated: January 2018

An Evaluation of Qualitative HIV-2 RNA Referral Testing

Opportunities Created by Diagnostic HCV and HIV Nucleic Acid Tests

OR: Steps you can take in the clinic to prevent HIV infections

Using all the data: Immunoassay signal-to-cutoff values provide useful information that should be considered in HIV diagnostic

HIV Testing: What s New? Kenneth H. Mayer, MD

2017 HIV AND HCV DIAGNOSTICS SURVEY REPORT

Clinical Education Initiative TESTING FOR HIV AND HCV: WHAT S CURRENT AND WHAT S COMING. Bernard M.

Supplementary Online Content

Ability to Identify Acute HIV Infections from Surveillance Data Varies by Diagnostic Testing Algorithm

AdvaMedDx Value Assessment Framework in Practice

AccuSet HIV-1/2 Performance Panel

HEALTH. Re: Interim Guidelines for Laboratories on the use of a new Diagnostic Testing Algorithm for Human Immunodeficiency Virus (HIV) Infection

Rapidly Growing Molecular Clusters of HIV in Texas. Analise Monterosso, MPH Epidemiologist Molecular HIV Surveillance Coordinator

HIV Serology Quality Assessment Program Summary for Panel HIVSER 2017Apr19

The how and why of Acute HIV Infection 1. How do we best diagnosis patients with acute HIV?

Unigold Recombigen HIV 1/2 Training for HIV Testing Sites. Updated: February 2018 Cicely Richard Office of HIV/AIDS

Linkage to care and initiating ART after diagnosis with acute or established HIV infection in 8 US emergency departments

Diagnosing HIV Infection AMNERIS E. LUQUE, M.D. PROFESSOR OF MEDICINE/INFECTIOUS DISEASES MEDICAL DIRECTOR, PARKLAND HIV SERVICES

SP.718 Special Topics at Edgerton Center: D-Lab Health: Medical Technologies for the Developing World

The Latest on HIV Testing. Dominika Seidman, MD MAS

Rapid testing algorithm performance in a low prevalence environment: NJ

2006 HIV Diagnostics Survey

Robert Wood Johnson Medical School NJ HIV: Status Update

TAP HERE TO SEE THE PRODUCT

HIV Serology Quality Assessment Program Summary for Panel HIVSER 2018Apr19

Rapid HIV Antibody Testing Update

Modernization of North Carolina s HIV control measures

CAPACITY OF THE HEALTHCARE SYSTEM TO INCREASE PROVISION OF HIV TESTING

Integrating HIV Screening Into

HIV Screening & Consent for Testing

Bruce D. Agins, MD MPH Medical Director, AIDS Institute Adherence 2017; Miami

HIV Serology Quality Assessment Program Summary for Panel HIVS Oct22

HOPE Follow-Up Algorithm: Unusual Cases. Urvi Parikh, PhD MTN Virology Core Regional Meeting Lab Breakout Sept 27-28, 2016, Cape Town

Technical Bulletin No. 104b

Shared Service Success

GOAL1 GOAL 2 GOAL 3 GOAL 4

How are testing technologies used to diagnose HIV infection?

AccuSet Anti-HIV-1 Mixed Titer Performance Panel

Comprehensive HIV/AIDS Resources and Linkages for Inmates (CHARLI) and Care Coordination (CC) Collaborative. Care Coordination

100 Abbott Park Road Abbott Park, IL Trade Name: ARCHITECT HIV Ag/Ab Combo Assay Approved Date: 18-JUN-2010

HIV Guideline Sakchai Dettrairat

The Challenges in Developing and Commercializing HIV Tests that are Useful in Differentiating VISP/R VISP/R Workshop Bethesda, MD March 2013

HUMAN IMMUNODEFICIENCY VIRUS (HIV) NON-IMMEDIATE NOTIFICATION STD PROGRAM. Version

Rubella rev Jan 2018

M E D I C A L L A B O R A T O R Y

Regional program of the East Europe and Central Asia Union of PLWH within the framework of the Global Fund New Funding Model

Cleveland Prevention Update. Zach Reau HIV Prevention Program Manager Ohio Department of Health

Potential Effect of Alternative HIV Testing Algorithms on HIV Case Surveillance

AccuVert HBV Seroconversion Panel PHM941(M) ( )

HIV Serology Quality Assessment Program Revised Summary for Panel HIVSER 2017Oct27

AccuSet Anti-HIV-1 Mixed Titer Performance Panel

Program to control HIV/AIDS

Immunologic Methods in Diagnosis of HIV Infection. Tehran Medical Sciences Branch, Islamic Azad

HIV Diagnostic Testing

M E D I C A L L A B O R A T O R Y

Implementing HIV Screening at Hub and Spoke Sites and Other Drug Treatment Settings

Comparison of the Geenius HIV-1/2 Supplemental Assay and HIV-1 Western blot for HIV rapid test confirmation from dried blood spots

AccuVert HIV-1 Seroconversion Panel PRB974 ( )

Kelly A. Curtis, M. Susan Kennedy, Kevin Delaney, Man Charurat, and S. Michele Owen

Obstetrics and HIV An Update. Jennifer Van Horn MD University of Utah

HIV 101: Fundamentals of HIV Infection

Clinical Education Initiative THE ROLE OF THE PRIMARY CARE CLINICIAN IN HIV CARE. Speaker: Antonia Urbina, MD

Case Studies in PrEP Management. Kevin L. Ard, MD, MPH Massachusetts General Hospital, National LGBT Health Education Center April 15, 2016

Module 3: Overview of HIV Testing Technologies

Negative Hepatitis C Reporting and Linkage to Care Outreach

Expression of HIV-1 Markers During Progression of Infection E E E Days Since 1st Bleed

A Case of False-Positive Test Results in a Pregnant Woman of Unknown HIV Status at Delivery

RNA PCR, Proviral DNA and Emerging Trends in Infant HIV Diagnosis

Epidemiology of HIV Among Women in Florida, Reported through 2014

Transcription:

The Evolving Landscape of HIV Prevention and Diagnosis Jenny R. McFarlane Texas Department of State Health Services HIV/STD/TB/Viral Hepatitis Unit

Is it okay if we just talk?

NHAS: A Call to ACT Reduce New HIV Infections Increase Access to Care and Improve Health Outcomes Reduce HIV-related Health Disparities and Health Inequities.

Newly Diagnosed HIV, PLWH, And Deaths 1980-2015 TEXAS 6,000 82,745 People Living with HIV 80,000 5,000 4,486 70,000 New dx and Deaths 4,000 3,000 2,000 New Diagnoses 60,000 50,000 40,000 30,000 People Living with HIV 1,000 Deaths 1,324 20,000 10,000 0 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 00 01 02 03 04 05 06 07 08 09 10 11 12 13 14 15 0

Texas HIV Treatment Cascade, 2015 80,000 100% 100% 70,000 60,000 77% 69% 80% 50,000 59% 60% 40,000 82,745 30,000 20,000 63,706 57,074 48,632 40% 20% 10,000 0 Individuals Living with HIV at end of 2015 At Least One Visit/Lab Retained In Care Achieved Viral Suppression 0%

The Bars!

Percentage of People Living with HIV and Percentage of HIV Transmissions at Each Stage of the Care Continuum, United States and Puerto Rico, 2012. Frieden TR et al. N Engl J Med 2015;373:2281-2287.

HIV Transmissions At Each Stage Of The Care Continuum Texas 2013 39% 5% 5% 5% 9% 55% 6% 32% 30% 14% Texans with HIV Transmissions People with undx infec:ons Persons dx but not in care In care no ART On ARV but not suppressed Viral suppression

What does this have to do with Testing Technology? Diagnosis is the first step. Do I know how to test? Am I using the best technology to detect early infection? Why is it important to detect early?

Serologic Assay Generations 1 st generation immunoassays (IA) Detects HIV antibody (Ab) IgG using viral lysates as the antigens (Ag) Western BLOT 1 st gen assay

2 nd Gen CLIA-Waived Point-of-Care Rapid HIV Tests Detects HIV IgG Antibody The image cannot be displayed. Your computer may not have enough memory to open the image, or the image may have been corrupted. Restart your computer, and then open the file again. If the red x still appears, you may have to delete the image and then insert it again. The image cannot be displayed. Your computer may not have enough memory to open the image, or the image may have been corrupted. Restart your computer, and then open the file again. If the red x still appears, you may have to delete the image and then insert it again. Clearview Complete ChemBio Stat Pak OraQuick Advance

3rd Generation Detects HIV 1/2 IgG and IgM Antibodies Siemans ADVIA Centaur - LAB Ortho VITROS Sei/ECIQ - LAB Ortho GS 1/2 +O - LAB Time to results 48 60 minutes Insti Unigold The image cannot be displayed. Your computer may not have enough memory to open the image, or the image may have been corrupted. Restart your computer, and then open the file again. If the red x still appears, you may have to delete the image and then insert it again. The image cannot be displayed. Your computer may not have enough memory to open the image, or the image may have been corrupted. Restart your computer, and then open the file again. If the red x still appears, you may have to delete the image and then insert it again. The image cannot be displayed. Your computer may not have enough memory to open the image, or the image may have been corrupted. Restart your computer, and then open the file again. If the red x still appears, you may have to delete the image and then insert it again.

Antigen/Antibody Combo Detects HIV 1 p24 Antigen and HIV 1/2 IgG and IgM Antibodies The image cannot be displayed. Your computer may not have enough memory to open the image, or the image may have been corrupted. Restart your computer, and then open the file again. If the red x still appears, you may have to delete the image and then insert it again.

Bio Plex 2200 Detects HIV 1/2 antibodies and p24 Antigen Load and run if no detection Negative Detection - runs again and will isolate what it found. Will tell us HIV 1, HIV 2, p24 antigen The image cannot be displayed. Your computer may not have enough memory to open the image, or the image may have been corrupted. Restart your computer, and then open the file again. If the red x still appears, you may have to delete the image and then insert it again.

If BioPlex Reactive what s Next?

HIV 1/2 Antibody Differentiation HIV 1/2 Geenius HIV 1/2 Multi Spot The image cannot be displayed. Your computer may not have enough memory to open the image, or the image may have been corrupted. Restart your computer, and then open the file again. If the red x still appears, you may have to delete the image and then insert it again. The image cannot be displayed. Your computer may not have enough memory to open the image, or the image may have been corrupted. Restart your computer, and then open the file again. If the red x still appears, you may have to delete the image and then insert it again.

Nucleic Acid The image cannot be displayed. Your computer may not have enough memory to open the image, or the image may have been corrupted. Restart your computer, and then open the file again. If the red x still appears, you may have to delete the image and then insert it again.

The image cannot be displayed. Your computer may not have enough memory to open the image, or the image may have been corrupted. Restart your computer, and then open the file again. If the red x still appears, you may have to delete the image and then insert it again.

Determine Combo Rapid HIV 1/2 Ag-Ab Test Alere 4 th generation technology The image cannot be displayed. Your computer may not have enough memory to open the image, or the image may have been corrupted. Restart your computer, and then open the file again. If the red x still appears, you may have to delete the image and then insert it again. Control Antigen Antibody The image cannot be displayed. Your computer may not have enough memory to open the image, or the image may have been corrupted. Restart your computer, and then open the file again. If the red x still appears, you may have to delete the image and then insert it again.

Determine HIV 1/2 Ag/Ab Early Infection Plasma Ag not detected most Acutes (Laperche, Rosenberg, Kilembe, Duong, Conway, Faraoni) Detects infection earlier than IgM-sensitive assays, not as early as Ag/Ab assays (Masciotra, JCV) Detected 40 54% early infections (Delaney, Masciotra, Dx conference) Whole Blood 0% Ag sensitivity, Acutes (Lewis, AIDS)

NATs on the Horizon The image cannot be displayed. Your computer may not have enough memory to open the image, or the image may have been corrupted. Restart your computer, and then open the file again. If the red x still appears, you may have to delete the image and then insert it again. The image cannot be displayed. Your computer may not have enough memory to open the image, or the image may have been corrupted. Restart your computer, and then open the file again. If the red x still appears, you may have to delete the image and then insert it again.

Acute Viral Infection Malaise/fatigue Fever/chills/night sweats Weight loss, loss of appetite Sore throat Nausea/vomiting/diarrhea Swollen lymph nodes Aching muscles or joints Rash Rarely headache, neurologic symptoms

Clinical Syndrome of Acute HIV 40% 90% develop symptoms of Acute HIV à 50% 90% w/ symptoms seek medical care Of those diagnosed with Acute HIV à 50% of patients were seen at least 3 times before diagnosis Kahn et al, NEJM 1998, Weintrob et al, Arch Int Med 2003

Prediction of the efficiency of HIV transmission according to HIV burden in the genital tract. Cohen M S, and Pilcher C D J Infect Dis. 2005;191:1391-1393 2005 by the Infectious Diseases Society of America

Acute HIV: Partner Notification Persons with acute HIV infection named 2.5 times as many sex partners 1.9 times as many partners newly diagnosed with HIV as did persons with new diagnosis of established HIV infection -Moore et al, JAIDS 2009

The Bars! Very T e s ti Linkage! Harm Reduction n g P ar t n e r T e s ti A R TA STI screen & tx Maintenance P r E P n g S P r E P

Transitions and Change Benefits and Challenges Please Ponder How can this improve your services, the quality of care your patients receive and the overall health of your community?

Case Studies 17 yo male rapid test INSTI prelim + Referred to clinic for follow up testing No show No blood specimen to NAAT test 26 yo male screening Ag/Ab Combo + Geenius negative NAAT +, VL 260K copies. 30 yo pregnant woman 3 rd gen + Geenius Indeterminate NAAT +

Transition to Best Practices Current Test Technology Used Staff training Technology Specimen Collection Messaging/Counseling Administration Link to Care Public Health Follow up

Specimen Collection HIV-1/2 Ag/Ab Combo No more than 5 days cold. Gold top, :ger top, spin before submit. NO DRY BLOOD SPOT. Reac:ve samples run in duplicate. Geenius HIV 1/2 Differen:a:on Reflex from reac:ve Ag/Ab Combo. 25 minute average run :me. Read immediately once test completed.

Why does this matter? Early id of infection has individual and positive public health benefits Laboratory testing offers the best potential for early diagnosis No test is perfect limitations of tests are important to understand relay to the client. New technology available now and on the horizon will likely change the algorithm

Where do I fit in? Testing Education Promotion Referral AND Follow-up And Follow-up Support YOU MATTER!

Laboratory Testing for the Diagnosis of HIV Infection Updated Recommendations http://www.cdc.gov/hiv/pdf/ HIVtestingAlgorithmRecommendation- Final.pdf

http://www.cdc.gov/hiv/testing/lab/guidelines/index.html

Resources To order materials from the DSHS Warehouse: http://www.dshs.state.tx.us/hivstd/info/edmat.shtm www.aphl.org/aphlprograms/infectious/hiv/pages/hiv- Diagnostic-Testing-Algorithm.aspx www.hivtestingconference.org www.hivforum.org/index.php? option=com_content&task=view&id=774&itemid=92 http://jid.oxfordjournals.org/content/202/supplement_2/ S270.full.pdf+html

Acknowledgements Michelle Owen, Ph.D- CDC Bernard Branson, MD Ann Robbins, Ph.D DSHS Margaret Vaaler, Ph.D DSHS Shelley Lucas, MPH - DSHS Isabel Clark, MS DSHS

Jenny R. McFarlane Prevention Manager Texas DSHS HIV/STD/TB Viral Hepatitis Unit Jenny.mcfarlane@dshs.state.tx.us (512) 533-3084